Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Srdan Verstovsek
Acute Myeloid Leukemia After Myelodysplastic Syndrome and Failure of Therapy With Hypomethylating Agents: An Emerging Entity With a Poor Prognosis
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Emerging Drugs for Myelofibrosis
Expert Opinion on Emerging Drugs
Pharmacology
Primary Myelofibrosis Associated Glomerulopathy: Significant Improvement After Therapy With Ruxolitinib
BMC Nephrology
Nephrology
A Phase I and Pharmacodynamic Study of AT9283, a Small-Molecule Inhibitor of Aurora Kinases in Patients With Relapsed/Refractory Leukemia or Myelofibrosis
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Effects of Ruxolitinib Treatment on Metabolic and Nutritional Parameters in Patients With Myelofibrosis From COMFORT-I
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
JAK2 Inhibitors: Are They the Solution?
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Efficacy of Ruxolitinib for Myelofibrosis
Expert Opinion on Pharmacotherapy
Medicine
Pharmacology
Sustained-Release Ruxolitinib: Findings From a Phase 1 Study in Healthy Subjects and a Phase 2 Study in Patients With Myelofibrosis
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Updates in the Management of Polycythemia Vera and Essential Thrombocythemia
Therapeutic Advances in Hematology
Hematology
Therapeutic Potential of JAK2 Inhibitors
The Journal of OncoPathology
‹
1
2
3
4
›
